Meridian Bioscience Inc (VIVO)

13.25
0.15 1.10
NASDAQ : Health Care
Prev Close 13.10
Open 12.85
Day Low/High 12.75 / 13.40
52 Wk Low/High 16.60 / 21.49
Volume 89.03K
Avg Volume 451.40K
Exchange NASDAQ
Shares Outstanding 42.20M
Market Cap 546.52M
EPS 0.80
P/E Ratio 18.24
Div & Yield 0.50 (3.90%)

Latest News

The VIVO Paradox: Analysts Bearish But Forecast 10.67% Gains

The VIVO Paradox: Analysts Bearish But Forecast 10.67% Gains

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Meridian Bioscience Inc. .

Oversold Conditions For Meridian Bioscience (VIVO)

Oversold Conditions For Meridian Bioscience (VIVO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Meridian Bioscience, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Meridian Bioscience, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Meridian Bioscience, Inc.

Meridian Bioscience (VIVO) Passes Through 4% Yield Mark

Meridian Bioscience (VIVO) Passes Through 4% Yield Mark

Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Meridian Bioscience Inc. were yielding above the 4% mark based on its quarterly dividend (annualized to $0.50), with the stock changing hands as low as $12.30 on the day.

Meridian Bioscience About To Put More Money In Your Pocket (VIVO)

Meridian Bioscience About To Put More Money In Your Pocket (VIVO)

Looking at the universe of stocks we cover at Dividend Channel, on 2/2/17, Meridian Bioscience Inc. will trade ex-dividend, for its quarterly dividend of $0.125, payable on 2/16/17.

Top Buys by Top Brass: EVP, Pres Global Operations Baldini's $129.2K Bet on VIVO

Top Buys by Top Brass: EVP, Pres Global Operations Baldini's $129.2K Bet on VIVO

A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.

That's Odd: Bearish VIVO Analysts See 39.06% Upside

That's Odd: Bearish VIVO Analysts See 39.06% Upside

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Meridian Bioscience Inc. .

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Meridian Bioscience, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Meridian Bioscience, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Meridian Bioscience, Inc.

Stock's Plunge Offers Dividend Lesson

Meridian Bioscience takes a big drop.

Insiders Now Seeing Red With VIVO At New 52-Week Low

Insiders Now Seeing Red With VIVO At New 52-Week Low

In trading on Wednesday, shares of Meridian Bioscience Inc. touched a new 52-week low of $10.75/share.

Meridian Bioscience Becomes Oversold

Meridian Bioscience Becomes Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Meridian Bioscience Inc.

Ex-Div Reminder for Meridian Bioscience (VIVO)

Ex-Div Reminder for Meridian Bioscience (VIVO)

Looking at the universe of stocks we cover at Dividend Channel, on 11/17/16, Meridian Bioscience Inc. will trade ex-dividend, for its quarterly dividend of $0.20, payable on 12/1/16.

VIVO: Insiders vs. Shorts

VIVO: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/31/2016 settlement date, and Meridian Bioscience Inc. is one of the most shorted stocks of the Russell 3000, based on 10.17 "days to cover" versus the median component at 6.43.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BBW, CMCO, FRBK, GLRE, HSII, VRTS, WEYS Downgrades: BID, BREW, ISIG, PSEC, SNE, VIVO Initiations: CCP, NVCR Read on to get TheStreet Quant Ratings' detailed report:

Meridian Bioscience is Oversold

Meridian Bioscience is Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Meridian Bioscience Inc.

VIVO Crosses Above Key Moving Average Level

VIVO Crosses Above Key Moving Average Level

In trading on Monday, shares of Meridian Bioscience Inc. crossed above their 200 day moving average of $19.64, changing hands as high as $19.75 per share.